Figures & data
Figure 1. A. Schematic of a device and cross section of the membrane portion. B. Sustained release of aspart from a typical device with triggering by applying heat or by laser irradiation. C. Pulsatile release from the same type of device using 30-min laser pulses (continuous wave, 808 nm, 570 mW/cm2). D. Effect of irradiation on blood glucose levels in diabetic Sprague–Dawley rats.
![Figure 1. A. Schematic of a device and cross section of the membrane portion. B. Sustained release of aspart from a typical device with triggering by applying heat or by laser irradiation. C. Pulsatile release from the same type of device using 30-min laser pulses (continuous wave, 808 nm, 570 mW/cm2). D. Effect of irradiation on blood glucose levels in diabetic Sprague–Dawley rats.](/cms/asset/f45a4bea-1509-4638-af01-e67780df99d2/iedd_a_930435_f0001_b.jpg)
Figure 2. A. Luminescence imaging of whole mice showing accumulation of PEG-coated radioluminescent 198Au nanoshells at tumor sites. B. Schematic of gold nanocage controlled-release system. Upon NIR irradiation, the pNIPAm shell (black) collapses so that the drug (red) is released. C. Release of model drug after triggering for 2 min at various irradiances.
![Figure 2. A. Luminescence imaging of whole mice showing accumulation of PEG-coated radioluminescent 198Au nanoshells at tumor sites. B. Schematic of gold nanocage controlled-release system. Upon NIR irradiation, the pNIPAm shell (black) collapses so that the drug (red) is released. C. Release of model drug after triggering for 2 min at various irradiances.](/cms/asset/1b30c278-323c-454f-8c91-692233129e88/iedd_a_930435_f0002_b.jpg)